Civica Rx, a non-profit generic drug maker, has announced that it plans to manufacture and sell insulin for no more than $30 a vial. It is expected to be available as soon as early 2024, pending federal approval.
LOS ANGELES TIMES – Xtandi, a wonder drug for prostate cancer, was developed at UCLA with substantial funding from the taxpayers through the Pentagon...
Pharmacies were once routinely bequeathed from one generation to the next, but, in interviews with more than a dozen pharmacists, many said the pressure of running an independent drugstore have them pushing their offspring toward other careers.
The World Health Organization on Friday said the new strain, named omicron, is a “variant of concern” that may pose a higher risk of reinfection than past mutations of the virus. Pfizer and BioNTech said they are investigating omicron, first labeled B.1.1.529, and can adapt their vaccine quickly if needed.
Kaiser Health News – The Biden administration and Congress are embroiled in high-stakes haggling over what urgent priorities will make it into the ever-shrinking...
Boosters will likely be offered broadly in the coming months. That, plus continued growth in initial vaccinations, could mean a huge gain in sales and profits for Pfizer and Moderna.
Recent Comments